Baricitinib vs Trastuzumab

Baricitinib vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Baricitinib and Trastuzumab.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S.

Molecular Weight: Baricitinib — 371.4170 g/mol.

Type: Baricitinib — Small molecule; Trastuzumab — Antibody.